Clinical trial
Efficacy and Safety of Roflumilast in Japanese Patients With Bronchial Asthma…
NCT00242307 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00242307 |
|---|---|
| Title | Efficacy and Safety of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 70 y) (APTA-2217-05) |
| Official title | A Confirmatory Study of APTA-2217 in Adult Patients With Bronchial Asthma (A Placebo-controlled Double-blind Comparative Study) |
| Lead sponsor | AstraZeneca, Industry |
| Collaborators | Tanabe Pharma Corporation Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Bronchial Asthma |
| Intervention type | Drug |
| Interventions | Roflumilast |
| Enrollment | 450 |
| Start date | May 1, 2004 |
| Primary completion | Sep 1, 2006 |
| Completion | Jun 1, 2007 |
| First posted | Oct 20, 2005 |
| Last update posted | Nov 2, 2016 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: